Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia

Immunity

Volumn 18, Issue 3, 2003, Pages 441-452

  Silvestri, Guido ^a   Sodora, Donald L ^b   Koup, Richard A ^b,c   Paiardini, Mirko ^a   O'Neil, Shawn P ^d   McClure, Harold M ^d   Staprans, Silvija I ^a   Feinberg, Mark B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CERCOCEBUS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOLOGY; MONKEY DISEASE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VIREMIA; VIRUS REPLICATION;

EID: 0037343278     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(03)00060-8     Document Type: Article

References (58)

1. Ameisen J.C., Capron A. Cell dysfunction and depletion in AIDS. the programmed cell death hypothesis Immunol. Today. 12:1991;102-105.
2. Appay V., Nixon D.F., Donahoe S.M., Gillespie G.M., Dong T., King A., Ogg G.S., Spiegel H.M., Conlon C., Spina C.A.et al. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192:2000;63-75.
3. Badley A.D., Pilon A.A., Landay A., Lynch D.H. Mechanisms of HIV-associated lymphocyte apoptosis. Blood. 96:2000;2951-2964.
4. Broussard S.R., Staprans S.I., White R., Whitehead E.M., Feinberg M.B., Allan J.S. Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease. J. Virol. 75:2001;2262-2275.
5. Cao Y., Qin L., Zhang L., Safrit J., Ho D.D. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 332:1995;201-208.
6. Chakrabarti L.A., Lewin S.R., Zhang L., Gettie A., Luckay A., Martin L.N., Skulsky E., Ho D.D., Cheng-Mayer C., Marx P.A. Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection. J. Virol. 74:2000;1209-1223.
7. Choremi-Papadopoulou H., Viglis V., Gargalianos P., Kordossis T., Iniotaki-Theodoraki A., Kosmidis J. Downregulation of CD28 surface antigen on CD4+ and CD8+ T lymphocytes during HIV-1 infection. J. Acquir. Immune Defic. Syndr. 7:1994;245-253.
8. Clerici M., Shearer G.M. A TH1→TH2 switch is a critical step in the etiology of HIV infection. Immunol. Today. 14:1993;107-111.
9. Douek D.C., McFarland R.D., Keiser P.H., Gage E.A., Massey J.M., Haynes B.F., Polis M.A., Haase A.T., Feinberg M., Sullivan J.L.et al. Changes in thymic function with age and during the treatment of HIV infection. Nature. 396:1998;690-695.
10. Douek D.C., Brenchley J.M., Betts M.R., Ambrozak D.R., Hill B.J., Okamoto Y., Casazza J.P., Kuruppu J., Kunstman K., Wolinsky S.et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature. 417:2002;95-98.
11. Finkel T.H., Tudor-Williams G., Banda N.K., Cotton M.F., Curiel T., Monks C., Baba T.W., Ruprecht R.M., Kupfer A. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat. Med. 1:1995;129-134.
12. Fleury S., de Boer R.J., Rizzardi G.P., Wolthers K.C., Otto S.A., Welbon C.C., Graziosi C., Knabenhans C., Soudeyns H., Bart P.A.et al. Limited CD4+ T-cell renewal in early HIV-1 infection. effect of highly active antiretroviral therapy Nat. Med. 4:1998;794-801.
13. Fultz P.N., Gordon T.P., Anderson D.C., McClure H.M. Prevalence of natural infection with simian immunodeficiency virus and simian T-cell leukemia virus type I in a breeding colony of sooty mangabey monkeys. AIDS. 4:1990;619-625.
14. Gehri R., Hahn S., Rothen M., Steuerwald M., Nuesch R., Erb P. The Fas receptor in HIV infection. expression on peripheral blood lymphocytes and role in the depletion of T cells AIDS. 10:1996;9-16.
15. Giorgi J.V., Hultin L.E., McKeating J.A., Johnson T.D., Owens B., Jacobson L.P., Shih R., Lewis J., Wiley D.J., Phair J.P.et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J. Infect. Dis. 179:1999;859-870.
16. Gougeon M.L., Lecoeur H., Dulioust A., Enouf M.G., Crouvoiser M., Goujard C., Debord T., Montagnier L. Programmed cell death in peripheral lymphocytes from HIV-infected persons. increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression J. Immunol. 156:1996;3509-3520.
17. Graziosi C., Pantaleo G., Gantt K.R., Fortin J.P., Demarest J.F., Cohen O.J., Sekaly R.P., Fauci A.S. Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. Science. 265:1994;248-252.
18. Grossman Z., Meier-Schellersheim M., Sousa A.E., Victorino R.M., Paul W.E. CD4+ T-cell depletion in HIV infection. are we closer to understanding the cause? Nat. Med. 8:2002;319-323.
19. Haase A.T. Population biology of HIV-1 infection. viral and CD4+ T cell demographics and dynamics in lymphatic tissues Annu. Rev. Immunol. 17:1999;625-656.
20. Hahn B.H., Shaw G.M., De Cock K.M., Sharp P.M. AIDS as a zoonosis. scientific and public health implications Science. 287:2000;607-614.
21. Hazenberg M.D., Otto S.A., Cohen Stuart J.W., Verschuren M.C., Borleffs J.C., Boucher C.A., Coutinho R.A., Lange J.M., Rinke de Wit T.F., Tsegaye A.et al. Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection. Nat. Med. 6:2000;1036-1042. a.
22. Hazenberg M.D., Stuart J.W., Otto S.A., Borleffs J.C., Boucher C.A., de Boer R.J., Miedema F., Hamann D. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation. a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART) Blood. 95:2000;249-255. b.
23. Hellerstein M., Hanley M.B., Cesar D., Siler S., Papageorgopoulos C., Wieder E., Schmidt D., Hoh R., Neese R., Macallan D.et al. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat. Med. 5:1999;83-89.
24. Ho D.D., Neumann A.U., Perelson A.S., Chen W., Leonard J.M., Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 373:1995;123-126.
25. Huang S., Barbour J., Deeks S., Huang J., Grant R., Ng V., McCune J.M. Reversal of human immunodeficiency virus type-1 associated hematosuppression. Clin. Infect. Dis. 30:2000;504-510.
26. Kaur A., Yang J., Hempel D., Gritz L., Mazzara G.P., McClure H., Johnson R.P. Identification of multiple simian immunodeficiency virus (SIV)-specific CTL epitopes in sooty mangabeys with natural and experimentally acquired SIV infection. J. Immunol. 164:2000;934-943.
27. Kaur A., Alexander L., Staprans S., Denekamp L., Hale C.L., McClure H., Feinberg M., Desrosiers R., Johnson R.P. Emergence of cytotoxic T lymphocyte escape mutations in nonpathogenic SIV infection. Eur. J. Immunol. 31:2001;3207-3217.
28. Koester S.K., Roth P., Mikulka W.R., Schlossman S.F., Zhang C., Bolton W.E. Monitoring early cellular responses in apoptosis is aided by the mitochondrial membrane protein-specific monoclonal antibody APO2.7. Cytometry. 29:1997;306-312.
29. Lifson J.D., Nowak M.A., Goldstein S., Rossio J.L., Kinter A., Vasquez G., Wiltrout T.A., Brown C., Schneider D., Wahl L.et al. The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection. J. Virol. 71:1997;9508-9514.
30. McCune J.M. The dynamics of CD4+ T-cell depletion in HIV disease. Nature. 410:2001;974-979.
31. Mellors J.W., Rinaldo C.R. Jr., Gupta P., White R.M., Todd J.A., Kingsley L.A. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 272:1996;1167-1170.
32. Meyaard L., Otto S.A., Jonker R.R., Mijnster M.J., Keet R.P., Miedema F. Programmed death of T cells in HIV-1 infection. Science. 257:1992;217-219.
33. Meyaard L., Otto S.A., Hooibrink B., Miedema F. Quantitative analysis of CD4+ T cell function in the course of human immunodeficiency virus infection. Gradual decline of both naive and memory alloreactive T cells. J. Clin. Invest. 94:1994;1947-1952.
34. Migueles S.A., Laborico A.C., Shupert W.L., Sabbaghian M.S., Rabin R., Hallahan C.W., Van Baarle D., Kostense S., Miedema F., McLaughlin M.et al. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat. Immunol. 3:2002;1061-1068.
35. Mitra D., Steiner M., Lynch D.H., Staiano-Coico L., Laurence J. HIV-1 upregulates Fas ligand expression in CD4+ T cells in vitro and in vivo. association with Fas-mediated apoptosis and modulation by aurintricarboxylic acid Immunology. 87:1996;581-585.
36. Mohri H., Perelson A.S., Tung K., Ribeiro R.M., Ramratnam B., Markowitz M., Kost R., Hurley A., Weinberger L., Cesar D.et al. Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J. Exp. Med. 194:2001;1277-1287.
37. Moses A., Nelson J., Bagby G.C. Jr. The influence of human immunodeficiency virus-1 on hematopoiesis. Blood. 91:1998;1479-1495.
38. Muro-Cacho C.A., Pantaleo G., Fauci A.S. Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J. Immunol. 154:1995;5555-5566.
39. Nowak M.A., Lloyd A.L., Vasquez G.M., Wiltrout T.A., Wahl L.M., Bischofberger N., Williams J., Kinter A., Fauci A.S., Hirsch V.M., Lifson J.D. Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection. J. Virol. 71:1997;7518-7525.
40. Orendi J.M., Bloem A.C., Borleffs J.C., Wijnholds F.J., de Vos N.M., Nottet H.S., Visser M.R., Snippe H., Verhoef J., Boucher C.A. Activation and cell cycle antigens in CD4+ and CD8+ T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection. J. Infect. Dis. 178:1998;1279-1287.
41. Pantaleo G., Menzo S., Vaccarezza M., Graziosi C., Cohen O.J., Demarest J.F., Montefiori D., Orenstein J.M., Fox C., Schrager L.K., Fauci A.S. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N. Engl. J. Med. 332:1995;209-216.
42. Pitcher C.J., Hagen S.I., Walker J.M., Lum R., Mitchell B.L., Maino V.C., Axthelm M.K., Picker L.J. Development and homeostasis of T cell memory in rhesus macaque. J. Immunol. 168:2002;29-43.
43. Rey-Cuille M.A., Berthier J.L., Bomsel-Demontoy M.C., Chaduc Y., Montagnier L., Hovanessian A.G., Chakrabarti L.A. Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease. J. Virol. 72:1998;3872-3886.
44. Roederer M., Dubs J.G., Anderson M.T., Raju P.A., Herzenberg L.A. CD8 naive T cell counts decrease progressively in HIV-infected adults. J. Clin. Invest. 95:1995;2061-2066.
45. Rosenberg E.S., Billingsley J.M., Caliendo A.M., Boswell S.L., Sax P.E., Kalams S.A., Walker B.D. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science. 278:1997;1447-1450.
46. Sachsenberg N., Perelson A.S., Yerly S., Schockmel G.A., Leduc D., Hirschel B., Perrin L. Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen. J. Exp. Med. 187:1998;1295-1303.
47. Sloand E.M., Young N.S., Kumar P., Weichold F.F., Sato T., Maciejewski J.P. Role of Fas ligand and receptor in the mechanism of T cell depletion in AIDS. effect on CD4+ lymphocyte depletion and HIV replication Blood. 89:1996;1357-1363.
48. Sodora D.L., Douek D.C., Silvestri G., Montgomery L., Rosenzweig M., Igarashi T., Bernacky B., Johnson R.P., Feinberg M.B., Martin M.A.et al. Quantification of thymic function by measuring T cell receptor excision circles within peripheral blood and lymphoid tissues in monkeys. Eur. J. Immunol. 30:2000;1145-1153.
49. Sodora D.L., Milush J., Ware F., Wozniakowski A., Montgomery L., McClure H.M., Lackner A.A., Marthas M., Hirsch V., Johnson R.P.et al. Decreased levels of recent thymic emigrants in peripheral blood of SIV infected macaques correlate with alterations within the thymus. J. Virol. 76:2002;9981-9990.
50. Sousa A.E., Carneiro B., Meier-Schellersheim M., Grossman Z., Victorino R.M. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to viral load. J. Immunol. 169:2002;3400-3406.
51. Staprans S.I., Dailey P.J., Rosenthal A., Horton C., Grant R.M., Lerche N., Feinberg M.B. Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection. J. Virol. 73:1999;4829-4839.
52. Ullum H., Lepri A.C., Victor J., Skinhoj P., Phillips A.N., Pedersen B.K. Increased losses of CD4+CD45RA+ cells in late stages of HIV infection is related to increased risk of death. evidence from a cohort of 347 HIV-infected individuals AIDS. 11:1997;1479-1485.
53. Walker B.D., Korber B.T. Immune control of HIV. the obstacles of HLA and viral diversity Nat. Immunol. 2:2001;473-475.
54. Watson A., Ranchalis J., Travis B., McClure J., Sutton W., Johnson P.R., Hu S.L., Haigwood N.L. Plasma viremia in macaques infected with simian immunodeficiency virus. plasma viral load early in infection predicts survival J. Virol. 71:1997;284-290.
55. Wei X., Ghosh S.K., Taylor M.E., Johnson V.A., Emini E.A., Deutsch P., Lifson J.D., Bonhoeffer S., Nowak M.A., Hahn B.H., Shaw G. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 373:1995;117-122.
56. Weiss R.A. Gulliver's travels in HIVland. Nature. 410:2001;963-967.
57. Zhang L., Lewin S.R., Markowitz M., Lin H.H., Skulsky E., Karanicolas R., He Y., Jin X., Tuttleton S., Vesanen M.et al. Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy. J. Exp. Med. 190:1999;725-732.
58. Zinkernagel R.M., Hengartner H. T-cell-mediated immunopathology versus direct cytolysis by virus. implications for HIV and AIDS Immunol. Today. 15:1994;262-268.